{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:16:55Z","timestamp":1792700215448,"version":"4.5.0"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2022,11,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>The Systolic Blood Pressure Intervention Trial (SPRINT) showed that intensive blood pressure control reduced cardiovascular morbidity and mortality. However, the legacy effect of intensive treatment is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the long-term effects of randomization to intensive treatment with the incidence of cardiovascular and all-cause mortality approximately 4.5 years after the trial ended.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>In this secondary analysis of a multicenter randomized clinical trial, randomization began on November 8, 2010, the trial intervention ended on August 20, 2015, and trial close-out visits occurred through July 2016. Patients 50 years and older with hypertension and increased cardiovascular risk but without diabetes or history of stroke were included from 102 clinic sites in the US and Puerto Rico. Analyses were conducted between October 2021 and February 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Randomization to systolic blood pressure (SBP) goal of less than 120 mm Hg (intensive treatment group; n\u2009=\u20094678) vs less than 140 mm Hg (standard treatment group; n\u2009=\u20094683).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Extended observational follow-up for mortality via the US National Death Index from 2016 through 2020. In a subset of 2944 trial participants, outpatient SBP from electronic health records during and after the trial were examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 9361 randomized participants, the mean (SD) age was 67.9 (9.4) years, and 3332 (35.6%) were women. Over a median (IQR) intervention period of 3.3 (2.9-3.9) years, intensive treatment was beneficial for both cardiovascular mortality (hazard ratio [HR], 0.66; 95% CI, 0.49-0.89) and all-cause mortality (HR, 0.83; 95% CI, 0.68-1.01). However, at the median (IQR) total follow-up of 8.8 (8.3-9.3) years, there was no longer evidence of benefit for cardiovascular mortality (HR, 1.02; 95% CI, 0.84-1.24) or all-cause mortality (HR, 1.08; 95% CI, 0.94-1.23). In a subgroup of participants, the estimated mean outpatient SBP among participants randomized to intensive treatment increased from 132.8 mm Hg (95% CI, 132.0-133.7) at 5 years to 140.4 mm Hg (95% CI, 137.8-143.0) at 10 years following randomization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>The beneficial effect of intensive treatment on cardiovascular and all-cause mortality did not persist after the trial. Given increasing outpatient SBP levels in participants randomized to intensive treatment following the trial, these results highlight the importance of consistent long-term management of hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01206062\">NCT01206062<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamacardio.2022.3345","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T11:12:04Z","timestamp":1665573124000},"page":"1138","source":"Crossref","is-referenced-by-count":72,"title":["Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control"],"prefix":"10.1001","volume":"7","author":[{"given":"Byron C.","family":"Jaeger","sequence":"first","affiliation":[{"name":"Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam P.","family":"Bress","sequence":"additional","affiliation":[{"name":"Informatics, Decision-Enhancement, and Analytic Sciences (IDEAS) Center, Veterans Affairs, Salt Lake City Health Care System, Salt Lake City, Utah"},{"name":"Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Bundy","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred K.","family":"Cheung","sequence":"additional","affiliation":[{"name":"Renal Section, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah"},{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Cushman","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Drawz","sequence":"additional","affiliation":[{"name":"Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen C.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora E.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Oparil","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael V.","family":"Rocco","sequence":"additional","affiliation":[{"name":"Section on Nephrology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Rapp","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina"},{"name":"Department of Social Science and Health Policy, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Supiano","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, University of Utah School of Medicine, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul K.","family":"Whelton","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff D.","family":"Williamson","sequence":"additional","affiliation":[{"name":"Section on Gerontology and Geriatric Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Jackson T.","family":"Wright","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Reboussin","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Pajewski","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"25","key":"hoi220058r1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study.","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"10305","key":"hoi220058r2","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S0140-6736(21)01921-8","article-title":"Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis.","volume":"398","author":"Rahimi","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"hoi220058r3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jamacardio.2017.1421","article-title":"Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis.","volume":"2","author":"Bundy","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"20","key":"hoi220058r4","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1056\/NEJMoa1901281","article-title":"Final report of a trial of intensive versus standard blood-pressure control.","volume":"384","author":"Lewis","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"hoi220058r5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.ihj.2018.12.001","article-title":"Legacy effect in medicine\u2014the expanding horizon!","volume":"70","author":"Wander","year":"2018","journal-title":"Indian Heart J"},{"issue":"14","key":"hoi220058r6","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension.","volume":"385","author":"Zhang","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"hoi220058r7","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1177\/1740774514537404","article-title":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).","volume":"11","author":"Ambrosius","year":"2014","journal-title":"Clin Trials"},{"issue":"19","key":"hoi220058r8","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race.","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"hoi220058r9","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/jgs.2005.53.issue-4","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"hoi220058r10","doi-asserted-by":"publisher","first-page":"S279","DOI":"10.1111\/jgs.12195","article-title":"Normative values of cognitive and physical function in older adults: findings from the Irish Longitudinal Study on Ageing.","volume":"61","author":"Kenny","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"hoi220058r11","doi-asserted-by":"publisher","DOI":"10.1080\/13854046.2021.1967450","article-title":"Robust demographically-adjusted normative data for the Montreal Cognitive Assessment (MoCA): results from the systolic blood pressure intervention trial.","author":"Sachs","journal-title":"Clin Neuropsychol"},{"issue":"5","key":"hoi220058r12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/gerona\/glv228","article-title":"Characterizing frailty status in the Systolic Blood Pressure Intervention Trial.","volume":"71","author":"Pajewski","year":"2016","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"hoi220058r14","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004966","article-title":"Comparison of expert adjudicated coronary heart disease and cardiovascular disease mortality with the National Death Index: results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.","volume":"6","author":"Olubowale","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"hoi220058r15","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1161\/HYPERTENSIONAHA.117.10479","article-title":"Blood pressure measurement in SPRINT (Systolic Blood Pressure Intervention Trial).","volume":"71","author":"Johnson","year":"2018","journal-title":"Hypertension"},{"issue":"12","key":"hoi220058r16","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1001\/jamainternmed.2020.5028","article-title":"Concordance between blood pressure in the systolic blood pressure intervention trial and in routine clinical practice.","volume":"180","author":"Drawz","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"7","key":"hoi220058r17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.21037\/atm","article-title":"Time-varying covariates and coefficients in Cox regression models.","volume":"6","author":"Zhang","year":"2018","journal-title":"Ann Transl Med"},{"issue":"408","key":"hoi220058r20","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1080\/01621459.1989.10478874","article-title":"The robust inference for the Cox proportional hazards model.","volume":"84","author":"Lin","year":"1989","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"hoi220058r21","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s10985-008-9094-0","article-title":"Flexible competing risks regression modeling and goodness-of-fit.","volume":"14","author":"Scheike","year":"2008","journal-title":"Lifetime Data Anal"},{"issue":"43","key":"hoi220058r23","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss","article-title":"Welcome to the tidyverse.","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw"},{"issue":"2","key":"hoi220058r25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v038.i02","article-title":"Analyzing competing risk data using the R timereg package.","volume":"38","author":"Scheike","year":"2011","journal-title":"J Stat Softw"},{"issue":"57","key":"hoi220058r26","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.21105\/joss","article-title":"The targets R package: a dynamic make-like function-oriented pipeline toolkit for reproducibility and high-performance computing.","volume":"6","author":"Landau","year":"2021","journal-title":"J Open Source Softw"},{"issue":"5","key":"hoi220058r27","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/HJH.0000000000003056","article-title":"Do recent meta-analyses truly prove that treatment with blood pressure-lowering drugs is beneficial at any blood pressure value, no matter how low? a critical review.","volume":"40","author":"Kreutz","year":"2022","journal-title":"J Hypertens"},{"issue":"12","key":"hoi220058r28","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jama.2020.14545","article-title":"Trends in blood pressure control among US adults with hypertension, 1999-2000 to 2017-2018.","volume":"324","author":"Muntner","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"hoi220058r29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1161\/CIRCULATIONAHA.121.057075","article-title":"Rise in blood pressure observed among US adults during the COVID-19 pandemic.","volume":"145","author":"Laffin","year":"2022","journal-title":"Circulation"},{"issue":"12","key":"hoi220058r31","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/jocs.v32.12","article-title":"Concordance between administrative data and clinical review for mortality in the randomized on\/off bypass follow-up study (ROOBY-FS).","volume":"32","author":"Quin","year":"2017","journal-title":"J Card Surg"},{"key":"hoi220058r18","volume-title":"Dynamic Regression Models for Survival Data","author":"Martinussen","year":"2007"},{"key":"hoi220058r30","volume-title":"The Surgeon General\u2019s Call to Action to Control Hypertension","author":"Substance Abuse and Mental Health Services Administration (US)","year":"2020"},{"key":"hoi220058r13","unstructured":"National Center for Health Statistics. National Death Index: user\u2019s guide. Accessed December 1, 2021. https:\/\/www.cdc.gov\/nchs\/data\/ndi\/ndi_users_guide.pdf"},{"key":"hoi220058r19","unstructured":"Therneau? T, Crowson? C, Atkinson? E. Using time dependent covariates and time dependent coefficients in the Cox model. Accessed DATE. https:\/\/cran.r-project.org\/web\/packages\/survival\/vignettes\/timedep.pdf"},{"key":"hoi220058r22","unstructured":"Jaeger? B. Table.glue: make and apply customized rounding specifications for tables. Accessed February 15, 2022. https:\/\/github.com\/bcjaeger\/table.glue"},{"key":"hoi220058r24","unstructured":"Therneau? TM. A package for survival analysis in R. Accessed February 15, 2022. https:\/\/CRAN.R-project.org\/package=survival"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2797064\/jamacardiology_jaeger_2022_oi_220058_1667925959.87033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T11:02:26Z","timestamp":1667991746000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2797064"}},"subtitle":["A Secondary Analysis of a Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2022.3345","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742359876.793596926","asserted-by":"object"}]},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,1]]}}}